Please login to the form below

Not currently logged in
Email:
Password:

omarigliptin

This page shows the latest omarigliptin news and features for those working in and with pharma, biotech and healthcare.

Merck drops once-weekly diabetes drug in US and EU

Merck drops once-weekly diabetes drug in US and EU

Merck &Co will no longer file for approval of once-weekly diabetes drug omarigliptin in the US or Europe, even though it is already on the market in Japan. ... As recently as last September, Merck was suggesting it would file for approval of omarigliptin

Latest news

More from news
Approximately 2 fully matching, plus 5 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
3 Monkeys Zeno

3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...

Latest intelligence

CHECKLIST 04: Let’s make your patient recruitment strategies a success
From how to generate insights to define your audience to drilling down those all-important key messages, our checklist has everything you need to think of, covered....
Multichannel engagement and the need for greater understanding of European markets
By Laurence Olding and Georgina James...
A snapshot of… Exscientia
...

Infographics